ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,708,618 | +38.6% | 87,472 | +2.2% | 2.56% | +54.7% |
| Q1 2023 | $3,398,364 | -4.0% | 85,558 | -2.8% | 1.66% | -20.7% |
| Q4 2022 | $3,540,924 | +40.8% | 88,017 | +12.5% | 2.09% | +35.6% |
| Q3 2022 | $2,515,000 | +30.5% | 78,251 | +28.6% | 1.54% | +36.0% |
| Q2 2022 | $1,927,000 | +19170.0% | 60,831 | +134.0% | 1.13% | +10200.0% |
| Q4 2017 | $10,000 | -44.4% | 26,000 | +32.0% | 0.01% | -31.2% |
| Q3 2017 | $18,000 | +125.0% | 19,700 | +18.0% | 0.02% | +128.6% |
| Q2 2017 | $8,000 | +100.0% | 16,700 | -32.4% | 0.01% | +75.0% |
| Q1 2017 | $4,000 | -42.9% | 24,700 | +190.6% | 0.00% | -42.9% |
| Q4 2016 | $7,000 | – | 8,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |